Prognostic, Predictive & Point-of-Care: Biomarkers from Research to Clinic

This conference brings together researchers from academic institutions and industry to discuss the utilization/deployment of biomarkers in research settings, the clinic, and point-of-care (POC) setting.

The focus of the conference begins with oncology (cancer) biomarkers but continues beyond into other disease areas such as cardiovascular disease biomarkers, CNS biomarkers, diabetes biomarkers, renal biomarkers, hepatic disease biomarkers.

Various classes of biomarkers are presented in this conference:  Classical cancer biomarkers, molecular signatures for cancer based on gene expression profiles, microRNA-based biomarkers, protein expression-based biomarkers, and epigenetic biomarkers.

One of the revolutions currently taking place is the movement of diagnostics towards the point-of-care and more recently with a smartphone or other telemetry-based approach towards the mobile point-of-care (mPOC).  This conference focuses on this emerging trend.

The ultimate goal of this conference is to bring together the stakeholders studying and utilizing biomarkers in many disease areas for up-to-date information exchange as well as extensive networking

Agenda Topics

• Cardiovascular and Metabolic Diseases
• Developing Diagnostics and Therapeutics in CNS Diseases using Biomarkers
• Examination of Prognostic versus Predictive Biomarkers
  • Algorithms for Prediction and Response
  • Commercial Impact and Clinical Adoption
  • Current Examples in the Clinic and their Impact
  • Disease Classes Addressed Currently
• Immunology Biomarkers and the Microbiome
• Oncology Biomarkers: Research to Clinical Trajectory
  • Various Cancer Classes such as Breast Cancer, Colorectal Cancer, Lung Cancer, GI Cancers
• Point-of-Care Diagnostics and Mobile Point-of-Care (mPOC) Diagnostics
  • Biomarkers
  • Technologies for Deployment
• R&D Pipeline of Markers with Associated Therapeutics
• The Impact of Next-Generation Sequencing (NGS) on Biomarker Analysis
  • Clinical Applications of RNA-Seq
• Various Classes of Biomarkers: Protein, Gene-Expression, microRNA, Epigenetic

Confirmed Speakers to date

Stuart Lipton, Professor and Scientific Director, Sanford Bunham Center for Neuroscience and Aging Research
David Cheresh, Distinguished Professor of Pathology , University of California-San Diego
Howard Federoff, EVP Health Sciences, Exec Dean, Professor of Neurology, Georgetown University Medical Center
Filip Janku, Assistant Professor, The University of Texas MD Anderson Cancer Center
Shawn Baker, Chief Science Officer, AllSeq Inc
David Kallend, Vice President, Global Medical Director, The Medicines Company
Christos Argyropoulos, Assistant Professor, Division of Nephrology, University of New Mexico
Anand Giddabasappa, Principal Scientist, Global Science and Technology, Pfizer
Scott Lippman, Associate Vice Chancellor for Cancer Research and Care, Moores Cancer Center & University of California-San Diego
Terri McClanahan, Director, Profiling & Expression, Merck Biologics Discovery
Denise Faustman, Director, Immunobiology Laboratory & Associate Professor of Medicine, Massachusetts General Hospital/Harvard Medical School
Hugh Bruck, Professor, Department of Mechanical Engineering, University of Maryland
George Zouridakis, Professor, Engineering Technology, Electrical & Computer Engineering, University of Houston
William Mobley, Distinguished Professor and Chair, Department of Neurosciences, University of California-San Diego
Donald Durden, Professor and Vice Chair for Research, Associate Director for Pediatric Oncology, University of California-San Diego Moores Cancer Center
Serguei Kozlov, Leidos Biomedical Research, Inc. Principal Scientist, Center for Advancer Preclinical Research, NIH
Sridhar Iyengar, Founder/Director, Misfit Wearables
Greg Jones, Director of Business Development and Technical Affairs, MDxHealth SA
Chamindie Punyadeera, Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
Jeff@selectbio.us
+1 510-857-4865